Progesterone Decreases in vitro Indoleamine 2, 3-dioxygenase Expression in Dendritic and CD4+ Cells from Maternal-Fetal Interface of Rats

Problem: Several mechanisms contribute to the tolerogenic state observed during pregnancy, such as the activity of the enzyme indoleamine 2, 3-dioxygenase (IDO). This initializes the catabolism of tryptophan, inducing T cells to apoptosis due to its deprivation and by the action of its catabolites i...

Full description

Saved in:
Bibliographic Details
Published inImmunological investigations Vol. 46; no. 5; pp. 447 - 459
Main Authors Bianchi, Pedro Kastein Faria da Cunha, Leandro, Rafael Magdanelo, Poscai, Aline Nayara, Yoshinaga, Tulio, Gonçalez, Patrícia Orlandini, Kfoury Junior, José Roberto
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 04.07.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Problem: Several mechanisms contribute to the tolerogenic state observed during pregnancy, such as the activity of the enzyme indoleamine 2, 3-dioxygenase (IDO). This initializes the catabolism of tryptophan, inducing T cells to apoptosis due to its deprivation and by the action of its catabolites in the placental microenvironment. Progesterone plays an important part on immunological tolerance mechanisms during pregnancy; however, there is no evidence it is related to IDO activity. Thus, this study aimed to investigate progesterone influence on the maternal-fetal interface of pregnant Wistar rats, by identifying IDO positive cells by immunophenotyping and flow cytometry under exogenous progesterone supplementation. Method of study: Placenta and embryo cells were cultured and separated into groups that received interferon γ or progesterone, supplemented or not with mifepristone. After 2 and 24 h, these were labeled with an anti-IDO and a series of antibodies specific to leucocytes and progesterone receptor and processed through flow cytometry analysis. Results: Progesterone induced a significant decrease in the expression of IDO in dendritic cells and CD4 + lymphocytes. Conclusion: The blocking of progesterone receptor on these cells by mifepristone restored IDO expression levels and may constitute evidence of the participation of this hormone through a direct route in these cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0882-0139
1532-4311
DOI:10.1080/08820139.2017.1296856